Close Menu

Golden Helix

Cautious optimism seems to be the prevailing mood among some of the bioinformatics vendors that have signed up to develop analysis tools for Illumina’s BaseSpace applications store.

NEW YORK (GenomeWeb News) – Myriad Genetics said in its quarterly filing with the US Securities and Exchange Commission that it has leased approximately 8,300 square feet of lab and office space in Saranac Lake, NY.

NEW YORK (GenomeWeb News) – Bioinformatics firm Golden Helix today announced it has set up an office in Japan and appointed Filgen its exclusive distributor in the region.

Expression Analysis announced yesterday that it has teamed up with Illumina and Golden Helix on an RNA-seq grant program.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Expression Analysis announced yesterday that it has teamed up with Illumina and Golden Helix on an RNA-Seq grant program.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Golden Helix and Expression Analysis today announced they will be developing a cloud-based analytic solution to increase adoption of RNA sequencing.

New Products: Aug 2, 2011

Premium

Golden Helix's SNP and Variation Suite 7.5, Mogene Services on 454 GS FLX+

As part of the collaboration, Golden Helix has added two new methods to its SNP & Variation Suite: combined multivariate and collapsing and kernel based adaptive cluster.

Golden Helix says the two new algorithms help researchers detect and analyze rare variants that may be missed by standard variant detection methods.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.